HomeMedical

Medical

spot_imgspot_img

HKTDC releases research report on biomedicine, Industry development drives GBA global tech leadership

HONG KONG, Sep 15, 2025 - (ACN Newswire) – Hong Kong’s healthcare sector surged by nearly 30% in the last decade, with the total number...

Sichuan Neautus TCM Files for Hong Kong IPO to Accelerate Domestic and Global Expansion

Company leverages dual-market strategy and technology-driven standardization to strengthen its leadership in China’s TCM sector and enter international markets. Sichuan Neautus Traditional Chinese Medicine Co.,...

Elevating Imaging, Empowering Flow – AGFA HealthCare at RSNA 2025

Enabling clinicians to stay in flow-anytime, anywhere-with an intelligent, cloud-powered Enterprise Imaging Platform that is streaming-enabled, deeply integrated, and tailored to your workspace. CARLSTADT, NEW...

Everest Medicines Announces 2025 Interim Results: ‘Dual-Engine’ Strategy Driving Strong Synergies Between Commercialization and R&D

On August 29, Everest Medicines (HKG: 1952) announced its interim results for the six months ended June 30, 2025. The Company’s total revenue for...

Hua Medicine Announces 2025 Interim Results

SHANGHAI, Aug 28, 2025 - (ACN Newswire) - Hua Medicine (the “Company”, HKEx: 2552) announced the unaudited consolidated results of the Company and its subsidiaries...

Lepu Biopharma (2157.HK) announces 2025 interim results

- ADC pipeline with multiple products entering key clinical stages - Revenue increased by 350% year-on-year Focusing on the field of tumor treatment, innovative biopharmaceutical company...

Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle

In the first half of 2025, the structural transformation of the pharmaceutical industry continued to deepen. Driven by favorable policies, product upgrades, and technological...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img